Science 37 taps NuvoAir to enable remote collection of lung health endpoints

By Nick Taylor

- Last updated on GMT

© Who_I_am / Getty Images
© Who_I_am / Getty Images

Related tags lung health respiratory health Remote monitoring

Science 37 has partnered with NuvoAir to incorporate connected devices for the remote collection of respiratory endpoints data into clinical trial designs.

NuvoAir has developed a digital respiratory care platform that features a suite of connected devices, including a CE marked and Food and Drug Administration cleared Bluetooth spirometer that enables patients to measure their lung health at home. The suite also includes a sensor that attaches to inhalers to track when and how patients take medications, an app that counts nightly coughs and more.

The platform, which also features an integrated patient app, clinician software and a wrap-around clinical service, has the potential to facilitate the remote collection of data for clinical trials. Rather than travel to a trial site to have their lung function assessed, patients could use the connected spirometer to capture data points such as the amount of air they can force from their lungs in one second.

NuvoAir’s potential to shift data collection from sites to the home aligns it with the focus of Science 37, the provider of an operating system designed to enable hybrid and decentralized clinical trials.

Science 37 has now secured the chance to incorporate NuvoAir’s remote spirometry capabilities into its clinical trials, enabling it to offer an expanded range of options to sponsors that want to capture data in respiratory studies remotely. 

In previous respiratory studies, we have used spirometry equipment and nurse training that replicates the equipment and training being used at brick-and-mortar sites. The partnership with NuvoAir affords us the opportunity to explore the use of additional connected respiratory devices that will provide more operational choices to our patients and pharma partners​,” said a spokesperson for Science 37.

The NuvoAir technology will slot into a portfolio that helped Science 37 generate sales of $19.3m in the second quarter, up 54% compared to the same period in 2021. However, net bookings were down, a trend the firm attributed to “a strategic shift in sales strategy to focus on larger studies, which generally have a longer bookings conversion timeline​,” and it made another loss as it invested in the business.

Related news

Related products

show more

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

How Sponsors Reduce Chaos in Decentralized Trials

How Sponsors Reduce Chaos in Decentralized Trials

Florence Healthcare | 08-Mar-2023 | Insight Guide

89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...

Standardizing data with NCI controlled terminology

Standardizing data with NCI controlled terminology

Formedix | 13-Feb-2023 | Technical / White Paper

The use of consistent terminology within and between studies is critical to enabling an efficient trial process. CDISC standards such as CDASH, SDTM, SEND...

Related suppliers

Follow us


View more